Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: A retrospective analysis

Julien Neveu(Fondation Lenval), Béatrice Desnous(Inserm), Nathalie Villeneuve(Henri Gastaut Hospital), Mathieu Milh(Inserm)

Epilepsy Research

October 2, 2021

10.1016/j.eplepsyres.2021.106780

Cited by 8

Related Papers

Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes

|Nature Genetics|2010|509

Diagnosis delay in West syndrome: misdiagnosis and consequences

|European Journal of Pediatrics|2012|88

Molecular and clinical descriptions of patients with <scp>GABA<sub>A</sub></scp> receptor gene variants (<i><scp>GABRA1</scp>, <scp>GABRB2</scp>, <scp>GABRB3</scp>, <scp>GABRG2</scp></i>): A cohort study, review of literature, and genotype–phenotype correlation

|Epilepsia|2022|80

Challenges and new perspectives of developmental cognitive EEG studies

|NeuroImage|2022|49

De novo mutations in CBL causing early-onset paediatric moyamoya angiopathy

|Journal of Medical Genetics|2017|41